Streamlining Precision Oncology Processes at the University of Nebraska Medical Center
The University of Nebraska Medical Center/Nebraska Medicine’s (UNMC/NM) Fred & Pamela Buffett Cancer Center (FPBCC) offers a novel precision oncology program that is dedicated to improving patients’ overall cancer care. Through the use of genomics and diagnostic tools, the UNMC/NM-FPBCC employs precision oncology to customize care for each cancer patient in order to enhance diagnostic opportunities and outcomes.
To strengthen the data enablement, decision support, and analytics processes within their precision oncology program, UNMC/NM has partnered, since 2015, with GenomOncology. GenomOncology’s precision oncology solutions are designed to be flexible and customizable to augment institutional workflows and processes. By integrating GenomOncology’s solutions into their workflows, UNMC/NM-FPBCC has been able to streamline the utilization and interpretation of complex precision oncology information within their precision oncology program.
During this 1-hour webinar, Allison Cushman-Vokoun of UNMC/NM and James Cole of GenomOncology will cover:
The challenges UNMC/NM-FPBCC faced with streamlining the precision oncology processes within their institution.
How UNMC/NM-FPBCC implemented GenomOncology’s precision oncology solutions to improve data enablement, decision support, and insights and analytics workflows within their precision oncology program.
The results and impacts of the implementation of GenomOncology’s solutions within UNMC/NM-FPBCC precision oncology program.